although I like lewis in charge now what can he pull out of the insm rabbit hat to break this insm share price drought of 10 years? although the stock has increased we're still sitting at $1.12 and we're much higher before the mmd results. and no fud you don't need to chime in on this and how insm is worth more - it's market cap maybe but anybody that's been here for the past 6+ years is still even at best unless they have avg down. Come on Lewis - show us iPlex!!!!
Hi lux19, I was about to ask the same question, but I think there are some pretty clear answers:
1. Signing a Japanese partner for NTM treatment (Lewis mentioned this in the conference)
2. Update revenue potential including bronchiactisis treatment in the mix
3. Partner with a 3rd party for Iplex ALS and DMD treatment
There's more but I gotta go!
Lux...Weren't we sued for patent infringement with iplex ???? My memory is a little foggy but I seem to recall something about the settlement that we had to pay for all future testing and if something looked promising we then have to split 50% of any profit?